Robert Doebele
CIK: 0001856681
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BOLD
Boundless Bio, Inc.
Officer
Discretionary Trading P&L
Holdings
About Doebele Robert
Doebele Robert (SEC CIK 0001856681) files insider reports with the SEC as Chief Medical Officer of Boundless Bio, Inc. (BOLD).
Signal8 holds 3 ownership filings by Doebele Robert (1 Form 3, 2 Form 4), filed between Feb 3, 2025 and Jan 26, 2026. Those filings report 2 transactions, from Feb 3, 2025 to Jan 23, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Doebele Robert's filings is in SAN DIEGO, CA.
Recent filings by Doebele Robert
Other insiders filing for Boundless Bio, Inc. (BOLD)
- TANG KEVIN, 10% Owner
- CRANDELL KEITH, 10% Owner
- ARCH Venture Fund IX, L.P., 10% Owner
- Whiting Nancy, Director
- Lim Jonathan E, Director
- Christensen James, Director